摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

16α-methyl-21-hydroxypregna-1,4,9(11)-triene-3,20-dione | 56016-90-1

中文名称
——
中文别名
——
英文名称
16α-methyl-21-hydroxypregna-1,4,9(11)-triene-3,20-dione
英文别名
21-hydroxy-16α-methylpregna-1,4,9(11)-triene-3,20-dione;(8S,10S,13S,14S,16R,17S)-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,10,12,13,14,15,16,17-decahydro-3H-cyclopenta[a]phenanthren-3-one;21-Hydroxy-16alpha-methylpregna-1,4,9(11)-triene-3,20-dione;(8S,10S,13S,14S,16R,17S)-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,12,14,15,16,17-octahydrocyclopenta[a]phenanthren-3-one
16α-methyl-21-hydroxypregna-1,4,9(11)-triene-3,20-dione化学式
CAS
56016-90-1
化学式
C22H28O3
mdl
——
分子量
340.463
InChiKey
QGWCZYPVHAHXQX-YYSFRLGLSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    511.6±50.0 °C(Predicted)
  • 密度:
    1.17±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3.1
  • 重原子数:
    25
  • 可旋转键数:
    2
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.64
  • 拓扑面积:
    54.4
  • 氢给体数:
    1
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    16α-methyl-21-hydroxypregna-1,4,9(11)-triene-3,20-dionepotassium carbonate三乙胺 、 sodium iodide 作用下, 以 乙腈 为溶剂, 反应 44.0h, 生成 替拉扎特
    参考文献:
    名称:
    Novel 21-aminosteroids that inhibit iron-dependent lipid peroxidation and protect against central nervous system trauma
    摘要:
    A novel class of 21-aminosteroids has been developed. Compounds within this series are potent inhibitors of iron-dependent lipid peroxidation in rat brain homogenates with IC50's as low as 3 microM. Furthermore, selected members enhance early neurological recovery and survival in a mouse head injury model. Significant improvement in the 1 h post-head-injury neurological status (grip test score) by as much as 168.6% of the control has been observed. The most efficacious compound in this assay (30) showed an increase in the 1-week survival of 78.6% as compared to 27.3% for the vehicle-treated mice in the head-injury model. Based on its biological profile, 21-[4-(2,6-di-1-pyrrolidinyl-4-pyrimidinyl)-1-piperazinyl]-16 alpha- methylpregna-1,4,9(11)-triene-3,20-dione monomethanesulfonate (30) was selected for further evaluation and is currently entering phase I clinical trials for the treatment of head and spinal trauma.
    DOI:
    10.1021/jm00166a010
  • 作为产物:
    参考文献:
    名称:
    [EN] NON-HORMONAL STEROID MODULATORS OF NF-?B FOR TREATMENT OF DISEASE
    [FR] MODULATEURS STÉROÏDES NON HORMONAUX DE NF-?B POUR LE TRAITEMENT DE MALADIES
    摘要:
    公开号:
    WO2011127048A3
点击查看最新优质反应信息

文献信息

  • Piperazinyl-bis(alkylamino)pyrimidine derivatives and process for
    申请人:Richter Gedeon Vegyeszeti Gyar Rt.
    公开号:US05550240A1
    公开(公告)日:1996-08-27
    An intermediate compound is disclosed that is useful in the preparation of a lipid-peroxidation inhibiting substance and that is selected from the group consisting of: 2,4-bis[1-adamantylamino]-6-(1-piperazinyl)pyrimidine; and 4,6-bis(1-adamantylamino)-2-(1-piperazinyl)pyrimidine; or a pharmaceutically acceptable acid addition salt thereof.
    披露了一种中间化合物,该化合物在制备抑制脂质过氧化的物质时非常有用,该化合物选自以下组:2,4-双[1-金刚烷基]-6-(1-哌嗪基)嘧啶;以及4,6-双(1-金刚烷基)-2-(1-哌嗪基)嘧啶;或其药用可接受的酸加成盐。
  • Steroids with pregnane skeleton, pharmaceutical compositions containing
    申请人:Richter Gedeon Vegyeszeti Gyar Rt.
    公开号:US05547949A1
    公开(公告)日:1996-08-20
    Novel, therapeutically active 21-aminosteroids of formula (I) ##STR1## with pregnane skeleton, are disclosed wherein two of X, Y and Z are a nitrogen atom each and the third one is a methine group; R.sup.1 and R.sup.2 are independently from each other, a primary amino group bearing as substituent a branched-chain C.sub.4-8 alkyl -alkenyl or -alkynyl group, or a C.sub.4-10 cycloalkyl group comprising 1 to 3 ring(s) and being optionally substituted by at least one C.sub.1-3 alkyl group; or R.sup.1 and R.sup.2 are each a spiro-heterocyclic secondary amino group containing at most 10 carbon atoms and optionally at least one oxygen atom as additional heteroatom; or one of R.sup.1 and R.sup.2 is an unsubstituted heterocyclic secondary amino group containing 4 to 7 carbon atoms and the other one is an above-identified primary amino group, an above-identified spiro-heterocyclic secondary amino group, or a heterocyclic secondary amino group containing 4 to 7 carbon atoms and substituted by at least one C.sub.1-4 alkyl group; and n is 1 or 2, as well as their acid addition salts and pharmaceutical compositions containing these compounds.
    披露了一种新颖的、具有治疗活性的21-甾体化合物,其具有孕甾烷骨架,分子式为(I) ##STR1##,其中X、Y和Z中有两个是氮原子,第三个是亚甲基;R1和R2分别独立地是,一个带有支链的C4-8烷基-烯基或-炔基基团的初级基,或者是一个含有1到3个环的C4-10环烷基,可被至少一个C1-3烷基基团取代;或者R1和R2都是含有最多10个碳原子和可选至少一个氧原子作为额外杂原子的螺杂环二级基;或者R1和R2中的一个是不含取代基的含有4到7个碳原子的杂环二级基,另一个是上述初级基,上述螺杂环二级基,或者是一个含有4到7个碳原子的杂环二级基,并且被至少一个C1-4烷基基团取代;n为1或2,以及它们的酸加成盐和含有这些化合物的药物组合物。
  • An Effective Method for the Preparation of 21-Chlorosteroids Using the Vilsmeier Reagent
    作者:P. G. M. Wuts、J. E. Cabaj、K. D. Maisto
    DOI:10.1080/00397919308018615
    日期:1993.8
    A simple procedure for the conversion of 21-steroidal alcohols to the corresponding 21-chlorides using the Vilsmeier reagent is described.
  • JACOBSEN, E. JON;MCCALL, JOHN M.;AYER, DONALD E.;VAN, DOORNIK FRED J.;PAL+, J. MED. CHEM., 33,(1990) N, C. 1145-1151
    作者:JACOBSEN, E. JON、MCCALL, JOHN M.、AYER, DONALD E.、VAN, DOORNIK FRED J.、PAL+
    DOI:——
    日期:——
  • NOVEL STEROIDS WITH PREGNANE SKELETON, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND PROCESS FOR PREPARING SAME
    申请人:RICHTER GEDEON VEGYESZETI GYAR R.T.
    公开号:EP0646126A1
    公开(公告)日:1995-04-05
查看更多

同类化合物

(5β)-17,20:20,21-双[亚甲基双(氧基)]孕烷-3-酮 (5α)-2′H-雄甾-2-烯并[3,2-c]吡唑-17-酮 (3β,20S)-4,4,20-三甲基-21-[[[三(异丙基)甲硅烷基]氧基]-孕烷-5-烯-3-醇-d6 (25S)-δ7-大发酸 (20R)-孕烯-4-烯-3,17,20-三醇 (11β,17β)-11-[4-({5-[(4,4,5,5,5-五氟戊基)磺酰基]戊基}氧基)苯基]雌二醇-1,3,5(10)-三烯-3,17-二醇 齐墩果酸衍生物1 黄麻属甙 黄芪皂苷III 黄芪皂苷 II 黄芪甲苷 IV 黄芪甲苷 黄肉楠碱 黄果茄甾醇 黄杨醇碱E 黄姜A 黄夹苷B 黄夹苷 黄夹次甙乙 黄夹次甙乙 黄夹次甙丙 黄体酮环20-(乙烯缩醛) 黄体酮杂质EPL 黄体酮杂质1 黄体酮杂质 黄体酮杂质 黄体酮EP杂质M 黄体酮EP杂质G(RRT≈2.53) 黄体酮EP杂质F 黄体酮6-半琥珀酸酯 黄体酮 17alpha-氢过氧化物 黄体酮 11-半琥珀酸酯 黄体酮 麦角甾醇葡萄糖苷 麦角甾醇氢琥珀酸盐 麦角甾烷-6-酮,2,3-环氧-22,23-二羟基-,(2b,3b,5a,22R,23R,24S)-(9CI) 麦角甾烷-3,6,8,15,16-五唑,28-[[2-O-(2,4-二-O-甲基-b-D-吡喃木糖基)-a-L-呋喃阿拉伯糖基]氧代]-,(3b,5a,6a,15b,16b,24x)-(9CI) 麦角甾烷-26-酸,5,6:24,25-二环氧-14,17,22-三羟基-1-羰基-,d-内酯,(5b,6b,14b,17a,22R,24S,25S)-(9CI) 麦角甾-8-烯-3-醇 麦角甾-8,24(28)-二烯-26-酸,7-羟基-4-甲基-3,11-二羰基-,(4a,5a,7b,25S)- 麦角甾-7,22-二烯-3-酮 麦角甾-7,22-二烯-17-醇-3-酮 麦角甾-5,24-二烯-26-酸,3-(b-D-吡喃葡萄糖氧基)-1,22,27-三羟基-,d-内酯,(1a,3b,22R)- 麦角甾-5,22,25-三烯-3-醇 麦角甾-4,6,8(14),22-四烯-3-酮 麦角甾-1,4-二烯-3-酮,7,24-二(乙酰氧基)-17,22-环氧-16,25-二羟基-,(7a,16b,22R)-(9CI) 麦角固醇 麦冬皂苷D 麦冬皂苷D 麦冬皂苷 B